Cargando…

Diagnosis for Chinese patients with light chain amyloidosis: a scoping review

BACKGROUND: Amyloid light chain (AL) amyloidosis is the most common systemic amyloidosis. The objective of this scoping review was to map the available literature on the diagnosis of AL amyloidosis in China. MATERIALS AND METHODS: The published academic papers related to the diagnosis of AL amyloido...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Meilan, Liu, Junru, Wang, Xiaohong, Cao, Xian, Gao, Xin, Xu, Lingjie, Liu, Wang, Pi, Jingnan, Wang, Bin, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316733/
https://www.ncbi.nlm.nih.gov/pubmed/37387123
http://dx.doi.org/10.1080/07853890.2023.2227425
_version_ 1785067770201767936
author Chen, Meilan
Liu, Junru
Wang, Xiaohong
Cao, Xian
Gao, Xin
Xu, Lingjie
Liu, Wang
Pi, Jingnan
Wang, Bin
Li, Juan
author_facet Chen, Meilan
Liu, Junru
Wang, Xiaohong
Cao, Xian
Gao, Xin
Xu, Lingjie
Liu, Wang
Pi, Jingnan
Wang, Bin
Li, Juan
author_sort Chen, Meilan
collection PubMed
description BACKGROUND: Amyloid light chain (AL) amyloidosis is the most common systemic amyloidosis. The objective of this scoping review was to map the available literature on the diagnosis of AL amyloidosis in China. MATERIALS AND METHODS: The published academic papers related to the diagnosis of AL amyloidosis were screened from 1 January 2000 to 15 September 2021. Chinese patients who have suspected AL amyloidosis were included. The included studies were categorized into accuracy studies and descriptive studies based on if the studies supplied the diagnostic accuracy data or not. The information on the diagnostic methods reported by included studies was synthesized. RESULTS: Forty-three articles were included for the final scoping review, with 31 belonging to descriptive studies and 12 having information on diagnostic accuracy. Although cardiac involvement was second top in Chinese patients with AL amyloidosis, a cardiac biopsy was rare. Next, we found light chain classification and monoclonal (M-) protein identification were essential methods for the diagnosis of AL amyloidosis in China. In addition, some combined tests (e.g. immunohistochemistry and serum free light chain, immunohistochemistry and immunofixation electrophoresis, and serum free light chain and immunofixation electrophoresis) can increase the sensitivity of the diagnosis. Finally, several adjuvant methods (e.g. Imaging, N-terminal-pro hormone BNP, and brain natriuretic peptide test) were important for AL amyloidosis diagnosis. CONCLUSION: This scoping review details the characteristics and results of the recently published studies on diagnosing AL Amyloidosis in China. Biopsy is the most important method for AL Amyloidosis diagnosis in China. In addition, combined tests and some adjuvant methods played essential roles in the diagnosis. Further research is required to determine an acceptable and feasible diagnostic algorithm after symptom onset. REGISTRATION:: KEY MESSAGES: 1. This scoping review details the characteristics and results of the recently published studies on diagnosing Amyloid light chain (AL) Amyloidosis in China. 2. Biopsy is the most important method for AL Amyloidosis diagnosis in China. 3. Combined tests and some adjuvant methods played essential roles in the diagnosis.
format Online
Article
Text
id pubmed-10316733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-103167332023-07-04 Diagnosis for Chinese patients with light chain amyloidosis: a scoping review Chen, Meilan Liu, Junru Wang, Xiaohong Cao, Xian Gao, Xin Xu, Lingjie Liu, Wang Pi, Jingnan Wang, Bin Li, Juan Ann Med Hematology BACKGROUND: Amyloid light chain (AL) amyloidosis is the most common systemic amyloidosis. The objective of this scoping review was to map the available literature on the diagnosis of AL amyloidosis in China. MATERIALS AND METHODS: The published academic papers related to the diagnosis of AL amyloidosis were screened from 1 January 2000 to 15 September 2021. Chinese patients who have suspected AL amyloidosis were included. The included studies were categorized into accuracy studies and descriptive studies based on if the studies supplied the diagnostic accuracy data or not. The information on the diagnostic methods reported by included studies was synthesized. RESULTS: Forty-three articles were included for the final scoping review, with 31 belonging to descriptive studies and 12 having information on diagnostic accuracy. Although cardiac involvement was second top in Chinese patients with AL amyloidosis, a cardiac biopsy was rare. Next, we found light chain classification and monoclonal (M-) protein identification were essential methods for the diagnosis of AL amyloidosis in China. In addition, some combined tests (e.g. immunohistochemistry and serum free light chain, immunohistochemistry and immunofixation electrophoresis, and serum free light chain and immunofixation electrophoresis) can increase the sensitivity of the diagnosis. Finally, several adjuvant methods (e.g. Imaging, N-terminal-pro hormone BNP, and brain natriuretic peptide test) were important for AL amyloidosis diagnosis. CONCLUSION: This scoping review details the characteristics and results of the recently published studies on diagnosing AL Amyloidosis in China. Biopsy is the most important method for AL Amyloidosis diagnosis in China. In addition, combined tests and some adjuvant methods played essential roles in the diagnosis. Further research is required to determine an acceptable and feasible diagnostic algorithm after symptom onset. REGISTRATION:: KEY MESSAGES: 1. This scoping review details the characteristics and results of the recently published studies on diagnosing Amyloid light chain (AL) Amyloidosis in China. 2. Biopsy is the most important method for AL Amyloidosis diagnosis in China. 3. Combined tests and some adjuvant methods played essential roles in the diagnosis. Taylor & Francis 2023-06-30 /pmc/articles/PMC10316733/ /pubmed/37387123 http://dx.doi.org/10.1080/07853890.2023.2227425 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Hematology
Chen, Meilan
Liu, Junru
Wang, Xiaohong
Cao, Xian
Gao, Xin
Xu, Lingjie
Liu, Wang
Pi, Jingnan
Wang, Bin
Li, Juan
Diagnosis for Chinese patients with light chain amyloidosis: a scoping review
title Diagnosis for Chinese patients with light chain amyloidosis: a scoping review
title_full Diagnosis for Chinese patients with light chain amyloidosis: a scoping review
title_fullStr Diagnosis for Chinese patients with light chain amyloidosis: a scoping review
title_full_unstemmed Diagnosis for Chinese patients with light chain amyloidosis: a scoping review
title_short Diagnosis for Chinese patients with light chain amyloidosis: a scoping review
title_sort diagnosis for chinese patients with light chain amyloidosis: a scoping review
topic Hematology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316733/
https://www.ncbi.nlm.nih.gov/pubmed/37387123
http://dx.doi.org/10.1080/07853890.2023.2227425
work_keys_str_mv AT chenmeilan diagnosisforchinesepatientswithlightchainamyloidosisascopingreview
AT liujunru diagnosisforchinesepatientswithlightchainamyloidosisascopingreview
AT wangxiaohong diagnosisforchinesepatientswithlightchainamyloidosisascopingreview
AT caoxian diagnosisforchinesepatientswithlightchainamyloidosisascopingreview
AT gaoxin diagnosisforchinesepatientswithlightchainamyloidosisascopingreview
AT xulingjie diagnosisforchinesepatientswithlightchainamyloidosisascopingreview
AT liuwang diagnosisforchinesepatientswithlightchainamyloidosisascopingreview
AT pijingnan diagnosisforchinesepatientswithlightchainamyloidosisascopingreview
AT wangbin diagnosisforchinesepatientswithlightchainamyloidosisascopingreview
AT lijuan diagnosisforchinesepatientswithlightchainamyloidosisascopingreview